Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Catherine Nester Discusses the BeginNGS Tool for Newborn Rare Disease Screening Awareness
Catherine Nester, RN, vice president of physician and patient strategies at Inozyme Pharma, highlights the importance of newborn screening for rare diseases and the impact of the BeginNGS diagnostic tool.
Dr Gustavo Fonseca on Key Takeaways From an FCS Analysis on Clinical Trial Enrollment
Gustavo Fonseca, MD, FACP, physician director of clinical research, Florida Cancer Specialists & Research Institute (FCS), discusses the results from a late phase complexity analysis on barriers to clinical trials regarding biopsy requirements.
Standardizing Digital Health Interventions for Depression May Improve Patient Adherence, Study Finds
Standardized reporting of patient adherence and engagement among digital health interventions for depression offers more effective comparisons between digital health tools and populations.